Stempoint Capital Lp - Sep 30, 2025 SCHEDULE 13G Report for Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

Filing Manager
STEMPOINT CAPITAL LP
Reporting Manager
StemPoint Capital LP
Security
Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
XLO
Shares outstanding
55.6M shares
Disclosed Ownership
4M shares
Ownership
7.2%
Form type
SCHEDULE 13G
Date filed
11/14/2025, 10:00 AM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
StemPoint Capital LP 7.2% 4M 0 4M /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
StemPoint Capital Management GP LLC 7.2% 4M 0 4M /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
Michelle Ross 7.2% 4M 0 4M /s/ Michelle Ross Michelle Ross